Daniel N. Fasanello

Represented a software company in connection with a venture debt facility

Represented a private equity firm in its $2.5 billion joint acquisition of two construction and infrastructure companies

Represented a technology services company in its acquisition by affiliates of an investment banking and financial services firm

Represented Knopp Biosciences LLC, a privately held drug development and discovery company, in the sale of its subsidiary to Biohaven Pharmaceutical Holding Company Ltd., with such transaction including a $100 million closing payment (cash and stock) and earn-out payments of up to $1.1 billion plus scaled royalties

Represented Sunbury Textile Mills, a producer of fabrics, in connection with its sale to Glen Raven Inc.

Represented TandemLife, a privately held company focused on advanced cardiopulmonary temporary support solutions, in connection with its sale to LivaNova for $250 million

Represented an employee benefits services company in connection with its sale to an insurance and consulting company

Represented Jvion, Inc., a company engaged in healthcare artificial intelligence, in connection with a growth equity investment by JMI Equity

Represented a private equity firm in its acquisition of a majority stake in an insurance brokerage and risk management firm

Represented a private equity firm in an equity investment of up to $600 million in a helicopter services company

Represented Knopp Biosciences LLC in the launch of Areteia Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with Population Health Partners, and a subsequent venture capital financing led by Bain Capital in an amount of up to $350 million